Collegium Pharmaceutical, Inc.

COLL US Health Care Pharmaceuticals
S&P 600
$22.75
-0.74%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Return on equity is healthy at 20.2%.
  • Return on capital employed is moderate at 10.6%.
  • Net profit margin is 8.1%.
  • Current assets comfortably cover current liabilities (current ratio 1.57).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.3

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Piotroski F-ScoreModerate
5 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$705.23M
Current Price$ 22.75
High / Low$ 50.79 / 22.64
Stock P/E17.913385
Book Value$ 9.61
Dividend Yield0%
ROCE10.59%
ROE20.16%
Current Ratio1.57
P/B Ratio2.3702855
EPS$ 0.46
PAT Margin8.05%
Cash PAT$67.05M
ICR2.18
Educational data only. Not a recommendation to buy, sell or hold any security.